Abstract

Niacin effectively lowers LDL and triglyceride levels and is the most effective agent available for raising HDL levels. Unfortunately, niacin is not well tolerated by many patients because of flushing, a process mediated primarily by prostaglandin D2. In a placebo-controlled, dose-ranging study conducted by the manufacturer of the prostaglandin D2 receptor antagonist laropiprant (not yet approved for marketing in …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.